• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超过二十年的主动脉弓再次手术经验:长期结果及死亡风险因素。

Over Two Decades of Experience in Aortic Arch Reoperations: Long-Term Outcomes and Mortality Risk Factors.

作者信息

Bozini Nikoleta, Piber Nicole, Vitanova Keti, Sideris Konstantinos, Herold Ulf, Guenzinger Ralf, Amabile Andrea, Georgescu Teodora, Krane Markus, Prinzing Anatol

机构信息

Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, School of Medicine & Health, Technical University of Munich, Lazarettstrasse 36, 80636 Munich, Germany.

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA 15213, USA.

出版信息

J Clin Med. 2025 Jun 10;14(12):4087. doi: 10.3390/jcm14124087.

DOI:10.3390/jcm14124087
PMID:40565833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12193799/
Abstract

After years of work in the field of aortic arch surgery, the technique has evolved, making this procedure relatively safe, with lasting results. Due to the increasing long-term survival and overall aging of the patient population, more patients require aortic arch reoperation. In the present study, the safety of aortic arch reoperations was analyzed in the long term, focusing on risk factors for mortality. Between 1999 and 2023, 108 patients were included in our study who underwent reoperation on aortic arch after prior operation on the aorta, the aortic valve, or a combination of both. The exclusion criteria were being aged under 18 years and transcatheter aortic valve implantation as a previous intervention. The principal outcome was the incidence of mortality, and additional outcomes of interest included cardiac re-reoperation, bleeding, a new aortic type B dissection, infective endocarditis, readmission due to a cardiac cause, coronary intervention and neurovascular complications, pacemaker implantation, and temporary mechanical circulatory support. The mean age was 56 ± 14 years, and 75% (81/108) of patients were male. In our study, we found age ( ≤ 0.01) and history of coronary artery disease ( = 0.01) to be preoperative risk factors for adverse outcomes. The mean time between the index operation and reoperation was 6.84 years (1.61-14.94). Indications for reoperation included dilatation (HR = 0.49, = 0.05), rupture or false aneurysm (HR = 2.08, = 0.08), dissection (HR = 1.41, = 0.30), and endocarditis (HR = 1.49, = 0.41). A main risk factor was the need for a salvage reoperation ( ≤ 0.01). Also, a longer operation ( = 0.04), cardiopulmonary bypass ( ≤ 0.01), and ventilation time ( ≤ 0.01), bleeding complications ( ≤ 0.01), and requiring temporary mechanical circulatory support ( = 0.04) were linked to higher mortality. The overall survival was 82% after 1 year, 73% after 5 years, and 56% after 10 years. In the multivariate Cox regression analysis, age (HR = 1.04, ≤ 0.01), the need for a salvage operation (HR = 5.38, = 0.01), a prolonged ventilation time (HR = 1.08, = 0.04), and bleeding complications (HR = 3.76, = 0.03) were associated with higher mortality. In the ROC analysis, an age over 57.5 years was associated with significantly lower overall survival ( ≤ 0.01). Aortic arch reoperations can be performed with acceptable long-term outcomes, but perioperative factors significantly influence early mortality. Salvage operations, bleeding complications, and prolonged ventilation were strong predictors of adverse outcomes. Older age, particularly >57.5 years, was independently associated with increased mortality risk.

摘要

经过多年在主动脉弓手术领域的工作,该技术不断发展,使这一手术相对安全且效果持久。由于患者群体长期生存率的提高和整体老龄化,越来越多的患者需要进行主动脉弓再次手术。在本研究中,对主动脉弓再次手术的长期安全性进行了分析,重点关注死亡风险因素。1999年至2023年期间,我们的研究纳入了108例患者,这些患者在先前接受主动脉、主动脉瓣或两者联合手术后接受了主动脉弓再次手术。排除标准为年龄在18岁以下以及先前干预为经导管主动脉瓣植入术。主要结局是死亡率,其他感兴趣的结局包括心脏再次手术、出血、新的B型主动脉夹层、感染性心内膜炎、因心脏原因再次入院、冠状动脉介入和神经血管并发症、起搏器植入以及临时机械循环支持。平均年龄为56±14岁,75%(81/108)的患者为男性。在我们的研究中,我们发现年龄(≤0.01)和冠状动脉疾病史(=0.01)是不良结局的术前风险因素。初次手术与再次手术之间的平均时间为6.84年(1.61 - 14.94)。再次手术的指征包括扩张(HR = 0.49,=0.05)、破裂或假性动脉瘤(HR = 2.08,=0.08)、夹层(HR = 1.41,=0.30)和心内膜炎(HR = 1.49,=0.41)。一个主要风险因素是需要进行挽救性再次手术(≤0.01)。此外,手术时间延长(=0.04)、体外循环(≤0.01)、通气时间(≤0.01)、出血并发症(≤0.01)以及需要临时机械循环支持(=0.04)与更高的死亡率相关。1年后总体生存率为82%,5年后为73%,10年后为56%。在多变量Cox回归分析中,年龄(HR = 1.04,≤0.01)、需要进行挽救性手术(HR = 5.38,=0.01)、通气时间延长(HR = 1.08,=0.04)和出血并发症(HR = 3.76,=0.03)与更高的死亡率相关。在ROC分析中,年龄超过57.5岁与总体生存率显著降低相关(≤0.01)。主动脉弓再次手术可以取得可接受的长期结局,但围手术期因素显著影响早期死亡率。挽救性手术、出血并发症和通气时间延长是不良结局的强预测因素。年龄较大,尤其是>57.5岁,与死亡风险增加独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb01/12193799/1eddc2a1557d/jcm-14-04087-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb01/12193799/1eddc2a1557d/jcm-14-04087-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb01/12193799/1eddc2a1557d/jcm-14-04087-g001.jpg

相似文献

1
Over Two Decades of Experience in Aortic Arch Reoperations: Long-Term Outcomes and Mortality Risk Factors.超过二十年的主动脉弓再次手术经验:长期结果及死亡风险因素。
J Clin Med. 2025 Jun 10;14(12):4087. doi: 10.3390/jcm14124087.
2
Endovascular treatment for ruptured abdominal aortic aneurysm.破裂性腹主动脉瘤的血管内治疗
Cochrane Database Syst Rev. 2017 May 26;5(5):CD005261. doi: 10.1002/14651858.CD005261.pub4.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Limited versus full sternotomy for aortic valve replacement.主动脉瓣置换术的有限胸骨切开术与全胸骨切开术对比
Cochrane Database Syst Rev. 2017 Apr 10;4(4):CD011793. doi: 10.1002/14651858.CD011793.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta-analysis.减少大型开放性血管或血管内手术中出血和输血的药物:系统评价和网络荟萃分析。
Cochrane Database Syst Rev. 2023 Feb 17;2(2):CD013649. doi: 10.1002/14651858.CD013649.pub2.
9
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.未治疗的霍奇金淋巴瘤患者化疗和放疗在第二原发性恶性肿瘤、总生存期和无进展生存期方面的优化:个体参与者数据分析
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2.
10
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.

本文引用的文献

1
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases.2024年欧洲心脏病学会外周动脉和主动脉疾病管理指南
Eur Heart J. 2024 Sep 29;45(36):3538-3700. doi: 10.1093/eurheartj/ehae179.
2
Aortic arch redo surgery: early and mid-term outcomes in 120 patients.升主动脉替换手术:120 例患者的早期和中期结果。
Eur J Cardiothorac Surg. 2023 Dec 1;64(6). doi: 10.1093/ejcts/ezad419.
3
Reoperations on the ascending aorta and aortic arch: A retrospective series of 453 patients.升主动脉和主动脉弓再手术:453 例回顾性系列。
J Thorac Cardiovasc Surg. 2024 Mar;167(3):897-907.e3. doi: 10.1016/j.jtcvs.2022.03.039. Epub 2022 Apr 20.
4
Aortic arch repair: lessons learned over three decades at Baylor College of Medicine.升主动脉修复:贝勒医学院三十多年的经验教训。
J Cardiovasc Surg (Torino). 2022 Aug;63(4):393-405. doi: 10.23736/S0021-9509.22.12376-1. Epub 2022 May 27.
5
Reoperative Aortic Arch Surgery under Mild Systemic Hypothermia: Two-Center Experience.轻度全身低温下的再次主动脉弓手术:两中心经验
Aorta (Stamford). 2021 Apr;9(2):60-66. doi: 10.1055/s-0041-1725073. Epub 2021 Oct 7.
6
Re-Operative Aortic Arch Surgery in a Contemporary Series.再次行主动脉弓手术的当代系列研究。
Semin Thorac Cardiovasc Surg. 2022 Summer;34(2):377-382. doi: 10.1053/j.semtcvs.2021.03.035. Epub 2021 May 8.
7
Reoperative Total Arch Repair Using a Trifurcated Graft and Selective Antegrade Cerebral Perfusion.三分支血管移植物和选择性顺行性脑灌注在全弓再手术中的应用。
Ann Thorac Surg. 2022 Feb;113(2):569-576. doi: 10.1016/j.athoracsur.2021.03.090. Epub 2021 Apr 12.
8
Modern practice and outcomes of reoperative cardiac surgery.现代心脏再手术的实践与结果。
J Thorac Cardiovasc Surg. 2022 Dec;164(6):1755-1766.e16. doi: 10.1016/j.jtcvs.2021.01.028. Epub 2021 Jan 23.
9
Editor's Choice - Aortic Re-operation After Replacement of the Proximal Aorta: A Systematic Review and Meta-Analysis.编辑精选 - 升主动脉置换术后再次主动脉手术:系统评价和荟萃分析。
Eur J Vasc Endovasc Surg. 2018 Oct;56(4):515-523. doi: 10.1016/j.ejvs.2018.06.038. Epub 2018 Jul 20.
10
Long-Term Outcomes of Open Arch Repair After a Prior Aortic Operation: Our Experience in 154 Patients.既往主动脉手术后开放弓部修复的长期预后:我们154例患者的经验。
Ann Thorac Surg. 2017 May;103(5):1406-1412. doi: 10.1016/j.athoracsur.2016.08.090. Epub 2016 Nov 5.